Evofem Biosciences Inc

OTCQB:EVFMUnited States

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is commercializing advanced products to address unmet needs in women’s sexual and reproductive health. Its first FDA-approved product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Phexxi is an advanced gel that works to prevent pregnancy without the use of hormones. Phexxi prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Phexxi is designed to address underserved and unmet needs in the birth control market. Using its platform, women can have a telehealth visit with a health care provider to determine their eligibility for a Phexxi prescription. It is also focused on commercializing SOLOSEC (secnidazole) 2g oral granules that address two pervasive sexual health infections.

Contact Information

Headquarters

12400 High Bluff Drive, Suite 600SAN DIEGO, CA, United States 92130

Phone

858-550-1900

Fax

302-636-5454

Executives

Interim Chairman of the Board of Directors, President, Chief Executive Officer

Saundra Pelletier

Chief Financial Officer, Company Secretary

Ivy Zhang

Independent Director

Kim Kamdar

Independent Director

Tony O'Brien

Independent Director

Lisa Rarick